GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » American Oncology Network Inc (NAS:AONCW) » Definitions » ROE % Adjusted to Book Value

American Oncology Network (American Oncology Network) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is American Oncology Network ROE % Adjusted to Book Value?

American Oncology Network's ROE % for the quarter that ended in Mar. 2024 was 0.00%. American Oncology Network's PB Ratio for the quarter that ended in Mar. 2024 was N/A. American Oncology Network's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.


American Oncology Network ROE % Adjusted to Book Value Historical Data

The historical data trend for American Oncology Network's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oncology Network ROE % Adjusted to Book Value Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - -

American Oncology Network Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of American Oncology Network's ROE % Adjusted to Book Value

For the Medical Care Facilities subindustry, American Oncology Network's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Oncology Network's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, American Oncology Network's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where American Oncology Network's ROE % Adjusted to Book Value falls into.



American Oncology Network ROE % Adjusted to Book Value Calculation

American Oncology Network's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

American Oncology Network's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Oncology Network ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of American Oncology Network's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


American Oncology Network (American Oncology Network) Business Description

Traded in Other Exchanges
Address
10485 NE 6th Street, Unit 3930, Bellevue, WA, USA, 98004
American Oncology Network Inc Formerly American Oncology Network LLC is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services through 24 oncology practices located in Arkansas, Louisiana, Indiana, Virginia, Ohio, Nevada, Iowa, Missouri, Washington, North Carolina, Michigan, Maryland, South Carolina, Arizona, and Georgia. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services.